
On February 9th, British American Tobacco (BAT) announced in its annual report that it plans to sell BAT Russia on March 11th, 2022 and complete the transfer by 2023, effectively exiting the Russian market.
In addition, due to the strong business interdependence between BAT Russia and Belarus companies, it has been decided to merge the Belarus business into the Russian company through a transfer.
It has been reported that the partner who has taken over BAT's business in Russia and Belarus is a collaborator of BAT in Russia.
Reference:
The acceleration of a new category will drive profitability forward until 2024.
Related reading:
According to the annual report released by BAT (British American Tobacco), the company's e-cigarette business in the United States experienced the most growth compared to other markets. BAT's emerging markets also saw an increase of over 50%.
British American Tobacco (BAT) is expected to generate revenues of £27.7 billion in 2022. Their electronic cigarette business is predicted to recover from losses and become profitable a year ahead of schedule.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.










